2026-10-12T10:56:06Z
https://api.figshare.com/v2/oai
oai:figshare.com:article/34048016
2026-10-01T17:29:11Z
category_1
category_4
category_7
category_12
category_21
category_272
category_873
category_734
category_64
category_132
portal_5
item_type_3
month_year_10_2026
<p>Fluorescent contrast agent concentrations applied to cell monolayers (i.e., concentrations in apical chambers) for each contrast agent (fluorescein, FITC-dextran and methylene blue) and each experimental concentration used (shown as percentages of maximal concentrations). All concentrations shown are in μg ml<sup>-1</sup>.</p>
Elena Monfort Sanchez (25157711)
Aaron F. Watson (25157714)
Tafhima Haider (14520521)
Despoina Chrysostomou (15147873)
Maelle Storder (25157717)
Nilanjan Mandal (25157720)
Paul Kelly (95510)
Julian R. Marchesi (165208)
James Avery (6193926)
Claire D. Bourke (12865193)
Alex J. Thompson (630738)
Biophysics
Biochemistry
Medicine
Cell Biology
Biotechnology
Environmental Sciences not elsewhere classified
Chemical Sciences not elsewhere classified
Biological Sciences not elsewhere classified
Cancer
Infectious Diseases
type ii diabetes
numerous physiological processes
inflammatory bowel disease
g ., lps
g ., lactulose
epithelial barriers serve
determine barrier damage
assess barrier integrity
epithelial barrier integrity
epithelial barrier function
translational gastroenterology research
molecular weights comparable
maintaining tissue homeostasis
fluorescent contrast agents
different disease contexts
microfluidic ‘ gut
mimic substances used
div >< p
cellular monolayer models
study gut permeability
epithelial barrier
substances used
molecular weight
different conditions
body tissue
barrier assessment
translational assessment
gut epithelium
fluorescent assessment
wider adoption
vivo </
vitro </
various cells
pamps )).
nutrient absorption
neuroimmune communication
multiple drawbacks
microbiota regulation
methylene blue
key component
indicating suitability
external environment
drive enteropathy
diverse range
cost alternatives
clinically approved
clinical settings
<p>Fluorescent contrast agent concentrations applied to cell monolayers (i.e., concentrations in apical chambers) for each contrast agent (fluorescein, FITC-dextran and methylene blue) and each experimental concentration used (shown as percentages of maximal concentrations). All concentrations shown are in μg ml<sup>-1</sup>.</p>
2026-10-01T17:28:59Z
Dataset
Dataset
10.1371/journal.pone.0358746.t001
https://figshare.com/articles/dataset/_p_Fluorescent_contrast_agent_concentrations_applied_to_cell_monolayers_i_e_concentrations_in_apical_chambers_for_each_contrast_agent_fluorescein_FITC-dextran_and_methylene_blue_and_each_experimental_concentration_used_shown_as_percentages_/34048016
CC BY 4.0